Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02991690 · ClinicalTrials.gov registry record · NA
Systemic Hypothermia in Acute Cervical Spinal Cord Injury
A NA study of Spinal Cord Injury, Acute, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 7
- Study locations
NCT02991690: Recruiting NA study of Spinal Cord Injury, Acute, sponsored by University of Miami.
NCT02991690 is a NA study of Spinal Cord Injury, Acute that is actively recruiting participants, run by University of Miami. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02991690, a NA study of Spinal Cord Injury, Acute, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 7
- Study locations
Study Summary
This study is a prospective multi-center trial designed to determine the safety profile and efficacy of modest (33ºC) intravascular hypothermia following acute cervical (C1 to C8) Spinal Cord Injury (SCI).
Primary Outcome
Improvement in ASIA Impairment Scale (AIS) after modest hypothermia. ASIA Motor Score: 0-100, with higher scores indicating better motor function
Conditions Studied
Interventions
- OTHER Hypothermia
Study Locations (7)
Arizona
- HonorHealth Research Institute with Barrow Brain and Spine - Phoenix
Florida
- Jackson Memorial Hospital - Miami
Georgia
- Emory University School of Medicine - Atlanta
Indiana
- Indiana University School of Medicine - Indianapolis
Maryland
- University of Maryland School of Medicine - Baltimore
Pennsylvania
- Thomas Jefferson University - Philadelphia
South Carolina
- Prisma Health - University of South Carolina - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2017-08-04 |
| Est. Completion | 2026-09 |
| Phase | NA |
What NCT02991690 shows while recruiting
NCT02991690 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Spinal Cord Injury, Acute appearing as the primary indexed condition, and to 1 intervention - of which Hypothermia is the first listed.
NCT02991690 lists 7 locations in 7 states (Arizona, Florida, Georgia).
Frequently Asked Questions
What is clinical trial NCT02991690 about?
NCT02991690 is a clinical study titled "Systemic Hypothermia in Acute Cervical Spinal Cord Injury". This study is a prospective multi-center trial designed to determine the safety profile and efficacy of modest (33ºC) intravascular hypothermia following acute cervical (C1 to C8) Spinal Cord Injury (SCI).
What is the current status of trial NCT02991690?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2017-08-04. Estimated completion is 2026-09.
What conditions does trial NCT02991690 study?
This clinical trial studies the following conditions: Spinal Cord Injury, Acute.
What interventions are being tested in trial NCT02991690?
The interventions under investigation include: Hypothermia (OTHER).
Who is sponsoring clinical trial NCT02991690?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02991690 being conducted?
This trial has 7 study locations across Arizona, Florida, Georgia, Indiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injury, Acute
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02991690's enrollment target sits among peer trials
120 762nd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI